Effects of 25-Hydroxyvitamin D\(_3\) on Proliferation and Osteoblast Differentiation of Human Marrow Stromal Cells Require CYP27B1/1\(\alpha\)-Hydroxylase

DSpace/Manakin Repository

Effects of 25-Hydroxyvitamin D\(_3\) on Proliferation and Osteoblast Differentiation of Human Marrow Stromal Cells Require CYP27B1/1\(\alpha\)-Hydroxylase

Citable link to this page

 

 
Title: Effects of 25-Hydroxyvitamin D\(_3\) on Proliferation and Osteoblast Differentiation of Human Marrow Stromal Cells Require CYP27B1/1\(\alpha\)-Hydroxylase
Author: Geng, Shuo; Glowacki, Julie; Zhou, Shuanhu

Note: Order does not necessarily reflect citation order of authors.

Citation: Geng, Shuo, Shuanhu Zhou, and Julie Glowacki. 2011. Effects of 25-hydroxyvitamin D\(_3\) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1\(\alpha\)-hydroxylase. Journal of Bone and Mineral Research 26(5): 1145-1153.
Full Text & Related Files:
Abstract: 1,25-Dihydroxyvitamin D3 [1,\(25(OH)_{2}D_{3}\)] has many noncalcemic actions that rest on inhibition of proliferation and promotion of differentiation in malignant and normal cell types. 1,\(25(OH)_{2}D_{3}\) stimulates osteoblast differentiation of human marrow stromal cells (hMSCs), but little is known about the effects of 25-hydroxyvitamin D3 [\(25(OH)D_{3}\)] on these cells. Recent evidence shows that hMSCs participate in vitamin D metabolism and can activate \(25(OH)D_{3}\) by CYP27B1/1\(\alpha\)-hydroxylase. These studies test the hypothesis that antiproliferative and prodifferentiation effects of \(25(OH)D_{3}\) in hMSCs depend on CYP27B1. We studied hMSCs that constitutively express high (hMSCs\(^{hi-1\ \alpha}\)) or low (hMSCs\(^{lo-1\ \alpha}\)) levels of CYP27B1 with equivalent expression of CYP24A1 and vitamin D receptor. In hMSCs\(^{hi-1\ \alpha}\), \(25(OH)D_{3}\) reduced proliferation, downregulated proliferating cell nuclear antigen (PCNA), upregulated p21\(^{Waf1/Cip1}\), and decreased cyclin D1. Unlike 1,\(25(OH)_{2}D_{3}\), the antiapoptotic effects of \(25(OH)D_{3}\) on Bax and Bcl-2 were blocked by the P450 inhibitor ketoconazole. The antiproliferative effects of \(25(OH)D_{3}\) in hMSCs\(^{hi-1\ \alpha}\) and of 1,\(25(OH)_{2}D_{3}\) in both samples of hMSCs were explained by cell cycle arrest, not by increased apoptosis. Stimulation of osteoblast differentiation in hMSCs\(^{hi-1\ \alpha}\) by \(25(OH)D_{3}\) was prevented by ketoconazole and upon transfection with CYP27B1 siRNA. These data indicate that CYP27B1 is required for \(25(OH)D_3\)'s action in hMSCs. Three lines of evidence indicate that CYP27B1 is required for the antiproliferative and prodifferentiation effects of \(25(OH)D_{3}\) on hMSCs: Those effects were not seen (1) in hMSCs with low constitutive expression of CYP27B1, (2) in hMSCs treated with ketoconazole, and (3) in hMSCs in which CYP27B1 expression was silenced. Osteoblast differentiation and skeletal homeostasis may be regulated by autocrine/paracrine actions of \(25(OH)D_{3}\) in hMSCs.
Published Version: doi:10.1002/jbmr.298
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179303/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10357692
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters